Gamithromycin 15% Solution For Injection

Verify with FDA CVM →

58 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
58
Total Reports
19
Deaths Reported
3280.0%
Death Rate

Active Ingredients

Gamithromycin 15% Solution For Injection

Administration Routes

SubcutaneousUnknownParenteralIntramuscularOther

Species Affected

Cattle 41
Human 9
Unknown 3
Pig 2
Sheep 2
Goat 1

Most Affected Breeds

Holstein-Friesian also known as Holstein 18
Unknown 12
Crossbred Bovine/Cattle 7
Aberdeen Angus 5
Cattle (unknown) 3
Charolais 2
Cattle (other) 2
Crossbred Porcine/Pig 2
Hereford cattle 2
Sheep (unknown) 2

Most Reported Reactions

Death 15
Injection site swelling 12
Lack of efficacy (bacteria) - NOS 10
Lack of efficacy - NOS 7
Injection site pain 6
Lameness 5
Cough 5
Skin lesion NOS 4
Fever 4
Pneumonia 4
Respiratory signs 4
Pain NOS 3

Outcome Breakdown

Outcome Unknown
27 (44.3%)
Died
18 (29.5%)
Recovered/Normal
11 (18.0%)
Ongoing
3 (4.9%)
Euthanized
2 (3.3%)

Data Summary

Metric Value
Total adverse event reports 58
Reports involving death 19
Case-fatality rate (reported events) 3280.0%
Distinct species in reports 6
Distinct breeds in reports 13
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Gamithromycin 15% Solution For Injection Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 58 adverse event reports referencing Gamithromycin 15% Solution For Injection, including 19 reports in which the animal died — a 3280.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Gamithromycin 15% Solution For Injection. Reported administration routes include Subcutaneous, Unknown, Parenteral, Intramuscular. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Gamithromycin 15% Solution For Injection reports are Cattle (41 reports), Human (9 reports), Unknown (3 reports), with Cattle accounting for the largest share. Within those species, Holstein-Friesian also known as Holstein (18), Unknown (12), Crossbred Bovine/Cattle (7) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Gamithromycin 15% Solution For Injection are Death (15), Injection site swelling (12), Lack of efficacy (bacteria) - NOS (10), Lack of efficacy - NOS (7). Of the 61 reports with a coded outcome, Outcome Unknown is the leading category at 44.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Gamithromycin 15% Solution For Injection.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial